The purpose of email discussions is to share information about medicines and practice in NSW public hospitals. NSW TAG members are encouraged to respond to email discussion requests for information. However it should be noted that information is only a current snapshot at the time the response is sent. The responses received are only representative of the hospitals participating in the discussion at the time (which may be small depending on the topic) and do not indicate a complete picture of current practices. It is recommended that email discussion topics are regularly brought to the attention of DTC meetings as they are likely to facilitate discussion of contemporary and emerging medicines and practice.
Completed email discussions can be found here (members only).
Access to completed email discussions is only available to NSW TAG members. Please note, members should not share or pass on identifiable information to non-NSW TAG members. Non-NSW TAG members who are interested in an email discussion topic may obtain de-identified email discussions by contacting NSW TAG at email@example.com
A list of the current open email discussions is shown below.
New email discussion coming soon
Recently Completed Email Discussions
- Use of very high cost medicines in those transitioning from paediatric to adult hospitals
- Are there safety issues associated with various metaraminol products?
- Dantrolene stocking for malignant hyperthermia
- Formulary status of lidocaine 0.4% infusion bags
- Prescribing nutritional feeds and supplements
Click here to access the email discussions running list of topics.
Click here to access the completed email discussions page (members only).
Page last updated 2 April 2020